Rising trend of oral cancers in India: a comprehensive review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252931Keywords:
Betel quid, Epidemiology, HPV infection, Oral cancer, Preventive strategies, Risk factors, Tobacco useAbstract
Oral cancer, encompassing malignancies of the lip, tongue, buccal mucosa and oropharynx, is a major public health concern in India, accounting for approximately one-third of the global burden with 77,000 new cases and 52,000 deaths annually. This comprehensive review examines the rising trend of oral cancers in India, focusing on epidemiology, risk factors, clinical characteristics, diagnostic challenges, management strategies and preventive approaches. The age-standardized incidence rate is 10.4 per 100,000, with higher prevalence among men and in regions like Uttar Pradesh, Bihar and the north eastern states. Key risk factors include tobacco use (smoked and smokeless), betel quid chewing, alcohol consumption, HPV infection and genetic predispositions, with squamous cell carcinoma dominating (>90% of cases). Advanced-stage diagnosis, limited access to screening and advanced diagnostics and reliance on Western treatment protocols contribute to poor outcomes. Preventive strategies, such as tobacco cessation, HPV vaccination and community-based screening, show promise in reducing incidence. This review emphasizes the need for region-specific research, affordable diagnostics and enhanced healthcare infrastructure to address the growing burden of oral cancers in India.
Metrics
References
Romero Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: https://doi.org/10.3322/caac.21660
Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer statistics, 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol. 2020;6:1063–75. DOI: https://doi.org/10.1200/GO.20.00122
National Cancer Registry Programme (NCRP). Consolidated Report of Hospital-Based Cancer Registries 2012–2016. Indian Council of Medical Research. 2020.
Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol. 2012;2:701932. DOI: https://doi.org/10.1155/2012/701932
Asthana S, Patil SS, Labani S. Tobacco-related cancers in India: A review of incidence and trends. Indian J Med Res. 2016;144(3):339–49.
Gupta B, Johnson NW. Emerging and established global risk factors for oral cancer: A review. Asian Pac J Cancer Prev. 2014;15(17):7031–6. DOI: https://doi.org/10.7314/APJCP.2014.15.15.5983
Global Adult Tobacco Survey (GATS). India 2016–17 Report. Ministry of Health and Family Welfare, Government of India. 2017.
Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9(7):667–75. DOI: https://doi.org/10.1016/S1470-2045(08)70173-6
Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirol. 2003;8(4):419–31. DOI: https://doi.org/10.1046/j.1440-1843.2003.00507.x
Warnakulasuriya S, Chen THH. Areca nut and oral cancer: Evidence for a causal relationship. Oral Dis. 2022;28(6):1401–12.
Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer. 2003;105(5):681–6. DOI: https://doi.org/10.1002/ijc.11114
D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral HPV infection and head and neck cancers in India. Oral Oncol. 2016;56:29–34.
Anantharaman D, Marron M, Lagiou P, Samant T, Vineis P, Mathew A, et al. Genetic polymorphisms and oral cancer risk in Indian populations. Oral Oncol. 2011;47(5):332–7. DOI: https://doi.org/10.1016/j.oraloncology.2011.06.015
Ray JG, Chatterjee R, Chaudhuri K. Oral submucous fibrosis: A global challenge. J Indian Med Assoc. 2019;117(2):83–8.
Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N. Oral cancer: Prevention, early detection and treatment. Oral Dis. 2015;21(7):833–42. DOI: https://doi.org/10.1596/978-1-4648-0349-9_ch5
Dandekar M, Dhawan J, Shrikhande SV. Challenges in oral cancer management in India. Indian J Surg Oncol. 2018;9(4):468–74.
Mallick S, Benson R, Rath GK. Radiation therapy for head and neck cancers in India: Current status and future perspectives. J Med Phys. 2019;44(1):1–6.
Shukla NK, Deo SVS, Jakhetiya A, Purkayastha J, Garg PK, Sharma S, et al. Neoadjuvant chemotherapy in advanced oral cancers: Indian experience. J Surg Oncol. 2017;116(5):629–35.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78. DOI: https://doi.org/10.1056/NEJMoa053422
Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375(19):1856–67. DOI: https://doi.org/10.1056/NEJMoa1602252
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet. 2005;365(9475):1927–33. DOI: https://doi.org/10.1016/S0140-6736(05)66658-5
Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of salivary biomarkers in oral cancer detection. Adv Clin Chem. 2018;86:23–70. DOI: https://doi.org/10.1016/bs.acc.2018.05.002
Downloads
Published
How to Cite
Issue
Section
